PureHealth, the largest integrated healthcare platform in the Middle East, has reaffirmed its commitment to the National In-Country Value (ICV) Programme by announcing a 30 percent increase in its 10-year commitment to local procurement. This decision brings PureHealth’s total commitment to AED 13 billion by 2032, demonstrating its dedication to supporting the national industrial strategy.
The announcement was made during the Make it in the Emirates Forum, held at the Abu Dhabi Energy Centre from May 31st to June 1st. PureHealth joined the National ICV Programme last year through a memorandum of understanding with the Ministry of Industry and Advanced Technology (MoIAT). In the inaugural Make it in the Emirates Forum in 2022, PureHealth pledged to procure AED 10 billion worth of products from local suppliers, including medicines and medical products. During this year’s forum, the company announced an additional AED 3 billion for local purchases, bringing the total value of its local procurement commitments to AED 13 billion. The National ICV Programme aims to enhance the growth and competitiveness of the UAE’s national industrial sector.
Omar Al Suwaidi, Under-Secretary of the Ministry of Industry and Advanced Technology, highlighted the success of the National ICV Programme in supporting entrepreneurship and innovation in the industrial sector. He stated that ICV-certified companies contributed an estimated AED 53 billion to the national economy in 2022 and emphasized the initiative’s role in directing more spending into the national economy.
PureHealth’s announcement aligns with the AED 10 billion of procurement opportunities unveiled at the Make it in the Emirates Forum. These opportunities complement last year’s AED 110 billion offtake agreements. PureHealth plans to allocate the opportunities across various categories of local procurement, including Technology and General Services, Medical Consumables and Supplies, and Pharmaceuticals. This strategic approach ensures a comprehensive integration of local suppliers in PureHealth’s supply chain.
Farhan Malik, Managing Director and CEO of PureHealth, expressed the company’s commitment to the In-Country Value Program and its contribution to building a sustainable and prosperous future for the UAE. He emphasized the importance of ICV in the healthcare sector, stating that it strengthens resilience and reduces dependency on external factors. As a national company, PureHealth aims to elevate the healthcare landscape in the UAE and actively support local healthcare manufacturing capabilities. The company envisions making the UAE the healthcare capital of the world by fostering local industries and future-proofing healthcare systems.
Farhan also praised the Make it in the Emirates Forum as an effective platform that brings together various sectors, including healthcare, to establish a sustainable and robust industrial ecosystem. He emphasized the significance of supporting the local biotech and medtech sectors to unlock the benefits of the Fourth Industrial Revolution.
Omar Al Suwaidi, Under-Secretary of the Ministry of Industry and Advanced Technology, commended the success of the National ICV Programme and its role in promoting entrepreneurship and innovation in the industrial sector. He highlighted the significant contribution made by ICV-certified companies, estimating that they added AED 53 billion to the national economy in 2022. Al Suwaidi stressed the programme’s ability to redirect higher portions of public and private sector spending into the national economy, thereby strengthening the industrial sector’s performance and sustainability.
PureHealth’s announcement aligns with the AED 10 billion of procurement opportunities unveiled at the Make it in the Emirates Forum, reinforcing the company’s commitment to supporting local suppliers and boosting the national economy. These additional opportunities build upon the AED 110 billion of offtake agreements announced last year, further solidifying PureHealth’s dedication to promoting local procurement and investing in the UAE’s manufacturing capabilities.
PureHealth’s increased commitment to local procurement demonstrates its dedication to supporting the UAE’s national industrial strategy and fostering economic growth in the healthcare sector. By actively engaging with local suppliers and investing in the country’s manufacturing capabilities, PureHealth aims to strengthen the UAE’s position as a global leader in healthcare while ensuring long-term benefits for the company and the government.
